Ventyx biosciences to participate in three upcoming investor conferences

San diego, aug. 27, 2025 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx) (“ventyx”, “company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases, today announced that company executives will participate in the following upcoming investor conferences: 2025 wells fargo healthcare conference location: boston, madate: friday, september 5, 2025time: 11:00-11:35 am edt morgan stanley 23 rd annual global healthcare conference location: new york, nydate: monday, september 8, 2025 h.c. wainwright 27th annual global investment conference location: new york, nydate: monday, september 8, 2025 a webcast of the wells fargo presentation will be available in the investors and news section of the ventyx website at  www.ventyxbio.com.
VTYX Ratings Summary
VTYX Quant Ranking